On December 20, 2022, FuelCell Energy (FCEL) reported disappointing Q4 2022 results badly missing market expectations both on sales and e...

On December 15, 2022, Guardant Health Inc. (GH) reported that its blood test for colorectal cancer performed worse than expected in a rec...

From the launch, Nifty Gateway sold unregistered securities in violation of federal securities laws. The Company promotes, offers, and s...

Compound DAO and the Partners sold Unregistered COMP directly to investors through the Compound protocol, in exchange for using the servi...

On October 11, 2022, Bloomberg published an article entitled “Bored-Ape Creator Yuga Labs Faces SEC Probe Over Unregistered Offerings,” s...

On September 28, 2022, Sunlight Financial Holdings Inc. (SUNL) announced that "an installer liquidity event and volatile interest rates w...

On March 16, 2022, Citrix shareholders voted in favor of the Merger Deal to sell Citrix to Vista Equity Partners and Elliott Investment M...

On November 15, 2022, short seller activist Scorpion Capital published a report alleging that Twist is “a cash-burning inferno that is no...

On June 14, 2022, Wave Life Sciences (NASDAQ: WVE) announced a $70 million offering at a price of $2.15/share and to RA Capital Managemen...

On June 28, 2022, 89bio (NASDAQ: ETNB) shares dropped over 5% after the Company proposed an underwritten public offering of $75M of share...

On November 4, 2021, Orchard Therapeutics (NASDAQ: ORTX) reported disappointing Q3 GAAP Ruslts with EPS and Revenue missed estimates. Goi...

On March 15, 2022, Esperion Therapeutics (NASDAQ: ESPR) announced that the Company’s CFO, Richard B. Bartram was stepping down from his p...

I sold our house in May 2022. Shortly after I put the tax money into Gemeni EARN because...why not? The Winkelvos twins were involved, ...

On May 24, 2022, Genocea Biosciences (NASDAQ: GNCA) announced that its Board of Directors voted to wind down the Company's ongoing operat...

On January 19, 2022, UCB (Euronext: UCB) and Zogenix (NASDAQ: ZGNX) announced that the companies have entered into a definitive agreement...

On June 27, 2022, Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) announced that they have entered into a definitive merger ...

On March 1, 2022, Karyopharm Therapeutics (KPTI) plunged after negative feedback from the FDA on its supplemental New Drug Application su...